New Criteria for Response to Treatment in Immunoglobulin Light Chain Amyloidosis Based on Free Light Chain Measurement and Cardiac Biomarkers: Impact on Survival Outcomes - Palladini, Giovanni; Dispenzieri, Angela; Gertz, Morie A.; Kumar, Shaji; Wechalekar, Ashutosh; Hawkins, Philip N.; Schönland, Stefan; Hegenbart, Ute; Comenzo, Raymond; Kastritis, Efstathios; Dimopoulos, Meletios A.; Jaccard, Arnaud; et al. (Journal of clinical oncology, 2012)
Keywords: Aged; Amyloidosis; Amyloidosis - blood; Amyloidosis - drug therapy; Amyloidosis - surgery; Amyloidosis - therapy; Biological and medical sciences; Biological Markers; Biomarkers - blood; Cohort Studies; Dexamethasone; Dexamethasone - therapeutic use; Female; Humans; Immunoglobulin Light Chains; Immunoglobulin Light Chains - blood; Immunology; Life Sciences; Male; Medical sciences; Melphalan; Melphalan - therapeutic use; Middle Aged; Retrospective Studies; Stem Cell Transplantation; Survival Analysis; Tumors; Heart; AL amyloidosis; Immunoglobulins; Cancerology; Prognosis; Treatment efficiency; Biological marker; Circulatory system; Light peptide chain; Survival